SYNOPSIS Mean homovanillic acid and 5-hydroxyindoleacetic acid concentrations were significantly low in the lumbar CSF of a group of patients with disseminated sclerosis (DS) who were severely disabled but not in the CSF of a less severely restricted group with DS. CSF concentrations were also low in a group of patients with superior cerebellar peduncular tremor due to DS and in a single patient with a similar tremor associated with a post-traumatic brain-stem lesion. The interpretation of abnormal CSF amine metabolite concentrations is discussed in the light of these findings.
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The finding of abnormally low concentrations of dopamine in the brains of subjects with Parkinson's disease (Ehringer and Hornykiewicz, 1960) and the marked therapeutic effect in this condition of L-dopa, the precursor of dopamine, has encouraged the investigation of brain amine metabolism in other neurological disorders. In particular, the concentrations of amine metabolites in the lumbar cerebrospinal fluid (CSF) are being used to provide some indication of amine turnover in the brain (Moir et al., 1970; Curzon, 1975, review) . Thus concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) give some measure of turnover of brain dopamine and 5-hydroxytryptamine respectively. Low concentrations of HVA, and to a less marked degree of 5-HIAA in CSF, have been found principally in Parkinson's disease (Bernheimer et al., 1966; Olsson and Roos, 1968; Pullar et al., 1970; Godwin-Austen et al., 1971 
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elbow and wrist, and independent adduction and abduction movements of individual digits (Denny-Brown, 1962) . Because this tremor occurs most commonly in patients with disseminated sclerosis (Charcot, 1872; Bonduelle, 1952) , amine metabolite studies were also made on CSF from patients with this disease but without superior cerebellar peduncular tremor. Low amine metabolite concentrations were found in severely impaired subjects whether they exhibited the tremor or not. The implications of these findings are discussed with respect to the interpretation of amine metabolite concentrations in the CSF.
PATIENTS
Eight patients with superior cerebellar peduncular tremor were studied of whom seven had disseminated sclerosis and one had a post-traumatic brain-stem lesion. In six patients the postural tremor was bilateral and symmetrical. In one of the patients with disseminated sclerosis the tremor was unilateral and in the traumatic case there was marked asymmetry. The group was severely disabled, partly because of the incapacitating nature of the tremor itself. Of the patients with disseminated sclerosis two were largely confined to bed and four to a wheelchair. None was able to walk unaided. All cases of disseminated sclerosis showed signs of optic atrophy and cord involvement. Six had evidence of an internuclear ophthalmoplegia.
Two groups of patients with disseminated sclerosis but without evidence of postural tremor were studied. The first group contained 10 patients who were all less severely disabled than the patients with superior cerebellar peduncular tremor, and none was confined to a wheelchair. Two of these patients had a cerebellar intention tremor. Three showed optic atrophy and four had evidence of brain-stem lesions. All had signs of a spinal cord lesion. A second group contained nine chronic and severely disabled patients without superior cerebellar peduncular tremor. All showed evidence of brain-stem and spinal cord lesions. Seven had evidence of optic atrophy and seven had evidence of cerebellar lesions.
A control group consisted of 10 patients with miscellaneous neurological disorders who were all normally mobile and without evidence of any movement disorder. No subject studied had been recently treated with drugs known to influence brain amine metabolism. Figure. Both had low HVA concentrations in the CSF. It is of interest that the patient with unilateral symptoms had normal 5-HIAA content.
Although there was little overlap between values found for subjects with cerebellar peduncular or severe disseminated sclerosis and those for the miscellaneous control group, overlaps with the group with less severe disseminated sclerosis were more marked (Figure) .
HVA was undetectable in one patient with superior cerebellar peduncular tremor and remained so after treatment for five days with 100 mg/day of the amine releaser tetrabenazine. The CSF HVA concentration of another patient with this condition rose from 6 ng/ml to 166 ng/ml when given 4 g L-dopa/day. This increase is comparable with increases of CSF HVA after administration of dopa to subjects with Parkinsonism (Godwin-Austen et al., 1971) . DISCUSSION It has thus been shown that mean concentrations of HVA in lumbar CSF were low in patients with superior cerebellar peduncle tremor and with severe disseminated sclerosis. Concentrations (Bowers, 1969) . Also the rate of mixing of the ventricular CSF (into which brain amine metabolites are secreted) with the contents of the lumbar sac may influence amine metabolite concentrations therein. It is of interest that HVA and 5-HIAA levels in the lumbar CSF both increase after a four hour period of increased motor activity (Post et al., 1973) . The extent to which such changes relate to increased mixing or increased amine turnover is unclear, although rat brain HVA does increase after increased activity (Bliss and Ailion, 1971) . These findings do imply, however, that severely altered mobility might well lead to secondary alteration of amine metabolite concentration in lumbar CSF. Postmortem determinations of brain amines would help to clarify their role in disseminated sclerosis. Very recently, Sonninen et al. (1973) have also reported low amine metabolite concentrations in the CSF of chronic and bedridden patients with disseminated sclerosis, although findings were less striking than those noted here. Probenecid was used to prevent transport of acidic amine metabolites from CSF to blood in an attempt to determine whether the low values were due to an abnormality of synthesis or of transport. Results on patients with disseminated sclerosis were proportionately as low as in the absence of probenecid but were no longer statistically significant, possibly because of the relative increase of standard error which is often found to follow use of the probenecid technique.
Results reported here and evidence of low amine metabolite concentrations in the CSF of patients with progressive supranuclear palsy, Shy-Drager disease, rigid Huntington's chorea, and motor neurone disease (Brody et al., 1970; Mendell et al., 1970 Mendell et al., , 1971 Curzon et al., 1972; Curzon, 1973) 
